病炎清Ⅰ号治疗流感A、B病毒感染的临床研究

Clinical Research of Bingyanqing Ⅰ Particles against Influenza A ,B Virus

目的观察病炎清Ⅰ号对流感A、B病毒感染患者的疗效。方法对可疑的流感A、B病毒感染者采用酶联免疫吸附试验（ELISA）进行抗原检测，筛选阳性患者108例随机分为A组、B组及C组，A组给予病炎清Ⅰ号颗粒；B组给予病炎清Ⅰ号颗粒＋病毒唑片；C组给予病毒唑片，比较三组患者疗效。结果A组和B组总有效率高于C组，差异具有统计学意义；B组总有效率虽高于A组，但差异没有统计学意义。结论病炎清Ⅰ号治疗流感病毒A、B型感染疗效满意。

Objective To observe the clinic efficacy of Bingyanqing Ⅰ Particles treating the respiratory infections because of influenza A, B virus. Methods Used ELISA Screening cases who are infected by flu-A, B virus will meet the standard, select 108 cases, randomly assigned to three groups, A, B and C. Give Bingyanqing Ⅰ Particles to the patients of group A, Bingyanqing Ⅰ Particles and Rirazole to group B, Rirazole to group C. Observe and compare the total efficiency. Results The total efficiency of group A and group B are better than group C, and the difference have statistical significance ; although the total efficiency of group B is higher than group A ,there has no statistical significance. Don＇t find toxic side effects in clinical observation. Conclusion there have satisfactory results that Bingyanqing Ⅰ Particles treat the infection of influenza A, B virus.